Precision BioSciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -23.6% | -8.3% | -3.2% | -26.8% | -25.1% | -6.9% | -1.3% | -3.2% | +0.6% | -5.6% | -5.8% | – | |
| – | -4.4% | -2.1% | +0.8% | +9.3% | +11.6% | -21.0% | +4.1% | -18.8% | -14.5% | -24.1% | +19.0% | – | |
| – | – | -788.0% | – | – | -90.9% | -243.7% | – | – | -1,278.4% | – | – | – | |
| – | -94.0% | +230.8% | -67.4% | +128.6% | +51.6% | +223.7% | -99.4% | +650.0% | +126.7% | -47.1% | +0.0% | – | |
| – | -99.4% | -161.9% | +7.7% | +128.6% | +51.6% | +223.7% | -96.2% | – | -2,011.8% | -64.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +1,317.8% | -98.2% | +431.8% | +58.6% | +80.5% | -50.4% | -68.7% | +4,572.5% | -99.0% | +0.0% | – | |
| – | – | – | -167.3% | – | – | – | – | – | – | -117.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.